APA (7th ed.) Citation

De Buck, S. S., Jakab, A., Boehm, M., Bootle, D., Juric, D., Quadt, C., & Goggin, T. K. (2014). Population pharmacokinetics and pharmacodynamics of BYL719, a phosphoinositide 3‐kinase antagonist, in adult patients with advanced solid malignancies. British journal of clinical pharmacology, 78(3), 543-555. https://doi.org/10.1111/bcp.12378

Chicago Style (17th ed.) Citation

De Buck, Stefan S., Annamaria Jakab, Markus Boehm, Douglas Bootle, Dejan Juric, Cornelia Quadt, and Timothy K. Goggin. "Population Pharmacokinetics and Pharmacodynamics of BYL719, a Phosphoinositide 3‐kinase Antagonist, in Adult Patients with Advanced Solid Malignancies." British Journal of Clinical Pharmacology 78, no. 3 (2014): 543-555. https://doi.org/10.1111/bcp.12378.

MLA (9th ed.) Citation

De Buck, Stefan S., et al. "Population Pharmacokinetics and Pharmacodynamics of BYL719, a Phosphoinositide 3‐kinase Antagonist, in Adult Patients with Advanced Solid Malignancies." British Journal of Clinical Pharmacology, vol. 78, no. 3, 2014, pp. 543-555, https://doi.org/10.1111/bcp.12378.